Iohexol Injectable Solution Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 240 mg/mL, 300 mg/mL, 350 mg/mL, 140 mg/mL
Reference Brands: Omnipaque(US & EU)
Category: Contrast Agent
Iohexol injectable solution is a contrast agent that enhances X-ray and CT imaging by increasing vascular and tissue radiopacity. It provides clear visualization of blood vessels, organs, and tissues, aiding in accurate diagnosis. Benefits include improved imaging quality, safety, rapid excretion, and support for effective disease detection and assessment.
Product Description:
Iohexol injectable solution, marketed as Omnipaque, is approved in the US by the FDA and in the EU via EMA for use as a contrast agent in diagnostic imaging. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety, efficacy, and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and broad global availability, enabling precise imaging for effective diagnosis and treatment planning worldwide.
Iohexol Injectable Solution — third party manufacturing & bulk supply
Iohexol Injectable Solution is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Iohexol Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Iohexol Injectable Solution →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Iohexol Injectable is a contrast agent used in diagnostic imaging procedures, including X-rays, CT scans, and angiography. It enhances the visibility of blood vessels, organs, and tissues to help healthcare professionals accurately diagnose medical conditions.
It contains iohexol, a non-ionic, water-soluble iodinated contrast medium that increases the contrast of structures in radiographic imaging. The solution is sterile and formulated for safe intravenous, intra-arterial, or other parenteral administration.
Common trade names include Omnipaque and Accupaque, depending on the manufacturer and region.
It is manufactured by several pharmaceutical companies, including GE Healthcare (Omnipaque) and multiple generic manufacturers in different countries.
The generic name is iohexol.
Brand names include Omnipaque, Accupaque, and various generics depending on the region.
It is manufactured globally, including the USA, Europe, India, and other regions, depending on the brand and pharmaceutical company.
Related Products
Gadobenate Dimeglumine
Strength:
529 mg/mL
Form: Injection
Reference Brands: MultiHance (USA)
View Details
Gadopiclenol
Strength:
0.25 mmol/mL
Form: Injection
Reference Brands: Elucirem (USA), Vueway(EU)
View Details
Perflutren
Strength:
0.19 mg/ ml
Form: Injection
Reference Brands: Definity (USA), Optison (USA), Luminity (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
